Study of SRK-015 for Spinal Muscular Atrophy

Trial Profile

Study of SRK-015 for Spinal Muscular Atrophy

Phase of Trial: Phase I

Latest Information Update: 08 Jan 2018

At a glance

  • Drugs SRK-015 (Primary)
  • Indications Spinal muscular atrophy
  • Focus Adverse reactions
  • Most Recent Events

    • 08 Jan 2018 New trial record
    • 03 Jan 2018 According to the Scholar Rock media release, this trial is anticipated to start in first half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top